Pulmatrix, Inc. (PULM) vs Reviva Pharmaceuticals Holdings, Inc. (RVPH)

Pulmatrix, Inc. and Reviva Pharmaceuticals Holdings, Inc. are both Biotechnology companies. Pulmatrix, Inc. and Reviva Pharmaceuticals Holdings, Inc. are of similar size ($5.2M and $5.0M). Across the 8 metrics below, Pulmatrix, Inc. leads on 4 and Reviva Pharmaceuticals Holdings, Inc. on 4.

Valuation

Metric PULM RVPH Biotechnology median
P/E n/m n/m 8.50
P/S 0.64 n/m 9.71
P/B 3.12 0.39 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.61 0.64
EV/Sales 0.82 n/m 9.21
Earnings yield (80.88%) (268.98%) (33.15%)
Free cash flow yield (86.74%) (291.12%) (25.50%)

Profitability

Metric PULM RVPH Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (111.99%) (176.60%) (56.36%)
Return on assets (85.74%) (79.46%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PULM RVPH Biotechnology median
Revenue growth (TTM) 6.96% — 6.02%
EPS growth (last fiscal year) 46.18% 69.56% 30.26%
Revenue growth, 5-year CAGR (0.26%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PULM RVPH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.70 3.56 4.72
Net debt to EBITDA 0.79 0.71 0.96

Dividend

Metric PULM RVPH Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PULM RVPH Biotechnology median
Market cap 5.15m 5.00m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack